Science Explorer Back to mapMap
Discussion
Researcher · CIC bioGUNE · Spain

María Pia Lenza

María Pia Lenza publishes mostly in Molecular Biology, Immunology and Organic Chemistry, on topics such as Glycosylation and Glycoproteins Research, Galectins and Cancer Biology and Carbohydrate Chemistry and Synthesis.

ORCID 0000-0002-9733-5020 OpenAlex
World rank
#2,685,967
of 7,710,434 ranked researchers
Rank in Spain
#59,156
of 204,306
Works
25
Citations
436
Citations per work
17.4
h-index
10
i10-index 10Top 76% in Molecular Biology
María Pia Lenza

What does María Pia Lenza research?

María Pia Lenza's work is mostly in Biochemistry, Genetics and Molecular Biology (46%), Immunology and Microbiology (24%), Chemistry (7%).

Life Sciences: 17 works · 69.1% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 45.6% of their workMolecular Biology: 10 works · 41.2% of their workCell Biology: 1 works · 4.4% of their workImmunology and Microbiology: 6 works · 23.5% of their workImmunology: 6 works · 23.5% of their workEverything else: 4 works · 16.2% of their workPhysical Sciences: 2 works · 7.4% of their workChemistry: 2 works · 7.4% of their workOrganic Chemistry: 2 works · 7.4% of their workHealth Sciences: 2 works · 7.3% of their workMedicine: 2 works · 7.3% of their workSurgery: 1 works · 4.4% of their workInfectious Diseases: 1 works · 2.9% of their workTHEIR WORKMaría Pia Lenza25works
Life Sciences69%Physical Sciences7%Health Sciences7%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1145.6%
    2. Immunology and Microbiology623.5%
  2. Everything else416.2%
    1. Chemistry27.4%
    1. Medicine27.3%
  1. 1Molecular Biology41% of their works
  2. 2Immunology24% of their works
  3. 3Organic Chemistry7% of their works
  4. 4Surgery4% of their works
  5. 5Cell Biology4% of their works
  6. 6Infectious Diseases3% of their works

Research topics

Which keywords describe María Pia Lenza's research?

The keywords of their largest research topics: Cancer, Glycans, Glycosylation, Galectins, Immune Regulation, Glycosidase Inhibitors, Oligosaccharide Synthesis and Cholesterol.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Cancer242 topics
  2. Glycans161 topic
  3. Glycosylation161 topic
  4. Galectins81 topic
  5. Immune Regulation81 topic
  6. Glycosidase Inhibitors51 topic
  7. Oligosaccharide Synthesis51 topic
  8. Cholesterol31 topic
  9. Dendritic Cells31 topic
  10. Immunity31 topic
  11. Immunotoxin31 topic
  12. Metabolism31 topic
  13. Ricin Poisoning31 topic
  14. Bioinformatics21 topic
  15. Education21 topic
  16. Protein21 topic
  17. Structure21 topic

Where does María Pia Lenza work?

María Pia Lenza's main affiliation in the publication record is CIC bioGUNE, Spain.

How many publications and citations does María Pia Lenza have?

OpenAlex counts 25 works and 436 citations for María Pia Lenza, an h-index of 10, ranking #2,685,967 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about María Pia Lenza. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.